03.12.2012 Views

ANNUAL REPORT 2007 | 2008 - Gimv

ANNUAL REPORT 2007 | 2008 - Gimv

ANNUAL REPORT 2007 | 2008 - Gimv

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

34. OFF-BALANCE SHEET OBLIGATIONS AND MAJOR PENDING LITIGATIONS (IN EUR 000)<br />

Name fund Year Currency Total<br />

commitment<br />

146 | <strong>Gimv</strong> Annual Report <strong>2007</strong>-<strong>2008</strong> | Statutory consolidation<br />

Total<br />

commitment 1<br />

CORPORATE INVESTMENT<br />

Buy out Fund 1999 EUR 12 400 12 400<br />

CapMan VIII Buyout 2006 EUR 20 000 20 000<br />

Corpeq Urals Fund2 1999 EUR 1 000 1 000<br />

DKB Emerging Europe L.P. 2001 USD 3 173 2 943<br />

Eagle Russia fund2 2006 USD 10 000 6 949<br />

EPF I 1996 EUR 1 524 1 524<br />

EPF II 2001 EUR 5 000 5 000<br />

EPF III 2006 EUR 5 000 5 000<br />

Fintech <strong>Gimv</strong> Fund <strong>2007</strong> USD 15 000 9 620<br />

Halder-<strong>Gimv</strong> Germany A2 2003 EUR 15 000 15 000<br />

Halder-<strong>Gimv</strong> Germany B2 2003 EUR 19 069 19 069<br />

Halder-<strong>Gimv</strong> Germany II <strong>2008</strong> EUR 81 250 81 250<br />

Industri Kapital 1997 EUR 3 500 3 500<br />

Kazakhstan Fund2 1997 EUR 2 000 4 432<br />

Lyceum Capital I 2000 EUR 75 000 75 000<br />

Lyceum Capital II <strong>2008</strong> GBP 21 000 26 389<br />

Nova Polonia 2000 EUR 10 450 10 450<br />

Pragma <strong>2007</strong> EUR 40 000 40 000<br />

Rabo Black Earth2 1996 EUR 300 242<br />

Rendex 1999 EUR 3 099 3 099<br />

Czech Fund2 2000 EUR 9 835 9 835<br />

Vectis 2004 EUR 3 000 3 000<br />

Outstanding<br />

commitment on<br />

31/03/08<br />

Value on<br />

31/03/08<br />

Total Corporate Investment 355 701 176 196 70 296<br />

CLEANTECH<br />

Emerald Technology Ventures II 2006 EUR 30 000 30 000<br />

Total Cleantech 30 000 21 694 8 009<br />

LIFE SCIENCES<br />

Abingworth Bio. II 1997 USD 3 006 4 193<br />

Abingworth Bio. IIIB 2001 USD 5 000 4 804<br />

Alta Biopharma Partners III 2004 USD 10 000 7 607<br />

Forward Ventures 4 2000 USD 5 000 4 729<br />

OBP II 1996 USD 1 000 882<br />

OBP II Annex 2002 USD 2 848 3 013<br />

OBP II Adj. 1996 USD 6 000 5 561<br />

OBP III 1999 USD 3 600 3 792<br />

OBP III Adjunct 1999 USD 14 400 14 786<br />

OBP IV 2001 USD 12 000 10 706<br />

Sofi nnova Venture III 1998 EUR 2 284 2 284<br />

Sofi nnova Venture IV 2000 EUR 10 000 10 000<br />

Sofi nnova Venture V (FR) 2005 EUR 7 500 7 500<br />

Total Life Sciences 79 859 5 548 37 093<br />

INFRASTRUCTURE<br />

DG Infra+ 3 <strong>2007</strong> EUR 30 000 30 000<br />

Total Infrastructure 30 000 27 413 2 588

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!